Compounds of formula (I) or pharmaceutically acceptable salts thereof, are inhibitors of glycogen phosphorylase and are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia, e.g. myocardial ischemia, or as cardioprotectants or inhibitors of abnormal cell growth.
The present invention is the following Amphotericin B derivative:
wherein each symbol is defined in description. The compound of the present invention has 16th position (X) is urea structure, cyclic structure, hydroxyalkyl or substituted monoalkylcarbamoyl. The compound of the present invention has antifungal activity.
本发明是以下两性霉素 B 衍生物:
其中各符号在说明中定义。本发明化合物的第 16 位(X)是脲结构、环状结构、羟烷基或取代的单烷基氨基甲酰基。本发明化合物具有抗真菌活性。
INDOLE-2-CARBOXYLIC ACID HYDRAZIDES AS GLYCOGEN PHOSPHORYLASE INHIBITORS
申请人:Prosidion Ltd.
公开号:EP1768957A2
公开(公告)日:2007-04-04
POLYENE MACROLIDE DERIVATIVE
申请人:Shionogi & Co., Ltd.
公开号:US20170190729A1
公开(公告)日:2017-07-06
The present invention is the following Amphotericin B derivative:
wherein each symbol is defined in description. The compound of the present invention has 16th position (X) is urea structure, cyclic structure, hydroxyalkyl or substituted monoalkylcarbamoyl. The compound of the present invention has antifungal activity.
Compounds of formula (I) or pharmaceutically acceptable salts thereof, are inhibitors of glycogen phosphorylase and are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia, e.g. myocardial ischemia, or as cardioprotectants or inhibitors of abnormal cell growth.